Abiopharma

News list

NALLEN JOHN 🟢 acquired 124.6K shares (2 derivative) of Fox Corp (FOX) at $62.31 ($4.3M) Transaction Date: Aug 11, 2026 | Filing ID: 056354

Full text

News bot Aug. 12, 2026, 9:15 p.m.
🔍 NALLEN JOHN (Executive)

Company: Fox Corp (FOX)

Report Date: 2026-08-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 124,551
Detailed Transactions and Holdings:
- Acquired 56,015 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 56,015.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 68,536 shares of Performance Stock Option (Right to Buy) at $62.31 per share (Derivative)
  Date: 2026-08-11 | Code: A | Expires: 2036-08-11 | equity_swap_involved: 0 | shares_owned_after: 68,536.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Each restricted stock unit represents the contingent right to receive one share of Fox Corporation's Class A Common Stock upon vesting.
- F2: The restricted stock units will vest one-third on each of August 15, 2027, August 15, 2028 and August 15, 2029.
- F3: The performance stock options may vest and become exercisable on August 11, 2029, based on the attainment of a 15% increase in the price of Fox Corporation's Class A Common Stock over the exercise price for at least 30 consecutive calendar days during the period from the date of grant to August 11, 2029.